(Q35617157)

9 August 2017

1 reference

title

Positron emission tomography scanning for the diagnosis and management of lung cancer (English)

1 reference

positron emission tomography

9 August 2017

1 reference

Bruce R Line

1

1 reference

PubMed ID

14697158

9 August 2017

Charles S White

series ordinal

2

1 reference

9 August 2017

1 February 2004

1 reference

Current Treatment Options in Oncology

9 August 2017

1 reference

9 August 2017

5

1 reference

9 August 2017

63-73

1 reference

9 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-004-0007-5

9 August 2017

0 references

cites work

Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.

1 reference

https://api.crossref.org/works/10.1007%2FS11864-004-0007-5

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-004-0007-5

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-004-0007-5

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-004-0007-5

Evaluation and management of solitary and multiple pulmonary nodules

21 January 2018

1 reference

12 December 2020

Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease

1 reference

12 December 2020

Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer.

1 reference

12 December 2020

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients

1 reference

12 December 2020

The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer

1 reference

12 December 2020

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

1 reference

12 December 2020

Evaluation of primary pulmonary carcinoid tumors using FDG PET

1 reference

12 December 2020

FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy

1 reference

12 December 2020

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

1 reference

12 December 2020

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

1 reference

12 December 2020

Application of annihilation coincidence detection to transaxial reconstruction tomography

1 reference

12 December 2020

Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F]fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan

1 reference

12 December 2020

Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study

1 reference

12 December 2020

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.

1 reference

12 December 2020

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

1 reference

12 December 2020

Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities

1 reference

12 December 2020

Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen.

1 reference

12 December 2020

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

1 reference

12 December 2020

The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study

1 reference

12 December 2020

The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.

1 reference

12 December 2020

Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer

1 reference

12 December 2020

Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma

1 reference

12 December 2020

Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG

1 reference

12 December 2020

Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.

1 reference

12 December 2020

Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.

1 reference

12 December 2020

The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas.

1 reference

12 December 2020

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

12 December 2020

Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

1 reference

12 December 2020

Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes

1 reference

12 December 2020

1 reference

12 December 2020

Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging

1 reference

12 December 2020

Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis

1 reference

12 December 2020

The impact of PET on the management of lung cancer: the referring physician's perspective.

1 reference

12 December 2020

The solitary circumscribed pulmonary nodule; study of seven hundred five cases encountered roentgenologically in a period of three and one-half years

1 reference

12 December 2020

The role of FDG-PET scan in staging patients with nonsmall cell carcinoma

1 reference

12 December 2020

10.1007/S11864-004-0007-5

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14697158